Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

BACKGROUND: Over the past five years, in most hospitals in England and Wales, incident reporting has become well established but it remains unclear how well reports match clinical adverse events. International epidemiological studies of adverse events are based on retrospective, multi-hospital case...

书目详细资料
Main Authors:	Olsen, S, Neale, G, Schwab, K, Psaila, B, Patel, T, Chapman, E, Vincent, C
格式:	Journal article
语言:	English
出版:	2007

相似书籍

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
由: Bahir A.Mshiemish
出版: (2017-03-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
由: Colleen M. Kingsbury, et al.
出版: (2024-09-01)

In light of recent events, we may have to see adverse effect profile in new perspective
由: Sahjid Mukhida, et al.
出版: (2024-11-01)

Internal Strengths for Adverse Life Events
由: Jian Zhao, et al.
出版: (2024-08-01)

Exploring the causes of adverse events in NHS hospital practice.
由: Neale, G, et al.
出版: (2001)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
由: Nicholls J, et al.
出版: (2017-02-01)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
由: Tingting Jiang, et al.
出版: (2025-01-01)

Failure to obtain informed consent should also be considered an adverse event
由: Gabriel M. Fonseca, et al.
出版: (2020-06-01)

Adverse events in British hospitals: preliminary retrospective record review.
由: Vincent, C, et al.
出版: (2001)

Case record review of adverse events: a new approach.
由: Woloshynowych, M, et al.
出版: (2003)

Adverse event management
由: Aline Gonzalez Vigani

The Adverse Event Paradox
由: Thomas Milovac
出版: (2022-05-01)

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
由: Tanattha Kitisopee, et al.
出版: (2022-12-01)

Embedding surveillance into clinical care to detect serious adverse events in pregnancy
由: Seale, A, et al.
出版: (2015)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
由: Xuejiao Pan, et al.
出版: (2022-01-01)

PrePex circumcision surveillance: Adverse events and analgesia for device removal.
由: Limakatso Lebina, et al.
出版: (2018-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
由: Astri Budikayanti, et al.
出版: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
由: Ming-Tao Wen, et al.
出版: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
由: Bin Zhao, et al.
出版: (2018-10-01)

AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
由: Yiming Li, et al.
出版: (2024-01-01)

Adverse events following immunization among the elderly having booster COVID-19 vaccine: an active surveillance in Guiyang city
由: Na YU, et al.
出版: (2022-09-01)

Understanding and responding to adverse events.
由: Vincent, C
出版: (2003)

Minor Adverse Events Postcolonoscopy
由: Catherine Dubé
出版: (2014-01-01)

Evaluating adverse events in databases
由: Katie Lovell, et al.
出版: (2023-10-01)

Adverse Events of DOACs in Children
由: Alessandra Bosch, et al.
出版: (2022-07-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
由: Wei Mao, et al.
出版: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
由: Fan Wu, et al.
出版: (2024-06-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
由: Kaito Yamashiro, et al.
出版: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
由: Han N, et al.
出版: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
由: Dong-Hui Lao, et al.
出版: (2021-06-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
由: Li Sun, et al.
出版: (2024-12-01)

Reinforcing Surveillance for Vaccine-Associated Adverse Events: The Advisory Committee on Causality Assessment
由: Robert Pless, et al.
出版: (1996-01-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
由: WANG Qian, et al.
出版: (2022-04-01)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
由: Yunha Noh, et al.
出版: (2023-06-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
由: AbdulAzeez Adeyemi Anjorin, et al.
出版: (2022-04-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
由: Patrícia Cabral Ferreira, et al.
出版: (2014-03-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
由: Patrícia Cabral Ferreira, et al.
出版: (2014-03-01)

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
由: Pernille Kähler Byskov, et al.
出版: (2024-06-01)

Pharmacist intervention and identification of adverse events related to treatment efficacy in cancer chemotherapy to improve clinical outcomes
由: Hironori Fujii
出版: (2024-12-01)

Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study
由: Rehana N. Rahman, et al.
出版: (2024-08-01)